Avid Bioservices Announces Appointment of Daniel Hart as Chief Financial Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Avid Bioservices (CDMO) PT Raised to $6 at H.C. Wainwright
July 17, 2018 10:22 AM EDTH.C. Wainwright raised its price target on Avid Bioservices (NASDAQ: CDMO) to $6.00 (from $5.00) while maintaining a Buy rating.
Analyst Joseph Pantginis commented, "Yesterday, CDMO reported F4Q18 and FY18 ended April 30, 2018, posting EPS of $0.03 and ($0.56), respectively, compared with our estimate of ($0.23) and ($0.87) and consensus of ($0.15) and... More
